Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New ablation technique takes aim at stubborn heart rhythm problem

NCT ID NCT07003412

Symptom relief Sponsor: Zentralklinik Bad Berka Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time

Summary

The PULSE PVC Registry collects data from European centers on patients with symptomatic premature ventricular contractions (PVCs) who receive focal pulsed field ablation using the Centauri Generator system. Researchers track whether the procedure reduces PVC burden to less than 5% at six months and compare outcomes with historical radiofrequency ablation results. The study aims to see how well this approach works across different PVC origins and to monitor safety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pulsed field ablation using the Centauri Generator system
What this could lead to
If it works, this could give doctors a new way to treat symptomatic PVCs that avoids some limitations of heat-based ablation.
What could go wrong
This is an observational registry, not a randomized trial, so it cannot prove cause and effect. Results may not apply to all patients or centers, and long-term outcomes beyond six months are not captured.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

200 people

The number who actually took part.

Started

Jun 2024

Finished

Sep 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

he study population consists of adult patients (age ≥18 years) with symptomatic premature ventricular contractions undergoing focal monopolar biphasic pulsed field ablation. All patients included must have been treated with the Centauri Generator system and have a minimum of 3 months of follow-up data available at the time of registry entry. The population is expected to be heterogeneous, including patients with and without structural heart disease, and PVCs originating from various anatomical sites. Patients will be enrolled across multiple European electrophysiology centers with varying procedural practices, enhancing the generalizability of the findings.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with symptomatic PVCs who underwent focal monopolar biphasic PFA * Use of Centauri Generator system * Minimum 3-month clinical follow-up at time of data entry Exclusion Criteria: * Incomplete procedural or follow-up data * Patients receiving exclusively RF ablation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Premature ventricular contraction (PVC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Ventricular Premature Complexes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Premature ventricular contraction (PVC) Pulsed field ablation

Contacts and locations

Locations

  • Zentralklinik Bad Berka

    Bad Berka, Thuringia, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.